PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
5 hedge funds and large institutions have $1.58M invested in PureTech Health in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.03% less ownership
Funds ownership: 0.42% → 0.39% (-0.03%)
16% less capital invested
Capital invested by funds: $1.88M → $1.58M (-$299K)
17% less funds holding
Funds holding: 6 → 5 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| 1 |
DP
Diadema Partners
Morristown,
New Jersey
|
+$2.03K |
| 2 |
PAP
Persistent Asset Partners
Hong Kong
|
+$1.27K |
Top Sellers
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$85.8K |
| 2 |
Millennium Management
New York
|
-$41.3K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
-$37 |
PRTC Hedge Fund Activity: Q4 2025 in Review
5 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q4 2025, worth a combined $1.58M — down 16% from $1.88M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PRTC and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Diadema Partners, adding an estimated $2.03K. The largest seller was Pentwater Capital Management, cutting an estimated $85.8K.
- 5 institutional investors held PureTech Health (PRTC) as of Q4 2025, down from 6 in Q3 2025.
- Funds reported $1.58M of PureTech Health stock for Q4 2025, down 16% quarter-over-quarter.
- 0 funds opened new PureTech Health positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest PureTech Health buyer in Q4 2025 was Diadema Partners, an estimated $2.03K added.
- The largest PureTech Health seller in Q4 2025 was Pentwater Capital Management, an estimated $85.8K sold.
Based on aggregated 13F filings for Q4 2025.